No Carolina / NY / Florida
Ph: 561.316.3330

FDA Continues Co-sponsorship of MedCon Conference with AFDO/RAPS Healthcare Products Collaborative

Summation

  • With a focus on fostering open discussions of the most pressing issues facing the medical device industry, the AFDO/RAPS Healthcare Products Collaborative recently announced that their new partnership will carry on Xavier Heath's 12-year legacy of delivering the MedCon Conference.
  • “MedCon has historically provided outreach and engagement with our colleagues in the medical products industry to discuss trends, innovations, and challenges in an educational setting.
  • FDA has made education of the device manufacturing community a high priority to help ensure the quality of FDA-regulated medical products.

FDA will continue its long-standing co-sponsorship of the MedCon Conference. With a focus on fostering open discussions of the most pressing issues facing the medical device industry, the AFDO/RAPS Healthcare Products Collaborative recently announced that their new partnership will carry on Xavier Heath’s 12-year legacy of delivering the MedCon Conference.

The MedCon 2022 Conference will be held virtually May 4 – 6, 2022. The event will bring together medical device regulators and industry experts from around the world for content-rich conference sessions that include uncommon collaboration, deep dialogue, and networking as close as your computer.

“The annual MedCon conference helps fulfill the Department of Health and Human Services’ and FDA’s important mission to protect public health,” says Gina Brackett, Director, Compliance Branch at FDA ORA Office of Medical Device and Radiological Health. “MedCon has historically provided outreach and engagement with our colleagues in the medical products industry to discuss trends, innovations, and challenges in an educational setting. We are pleased that this new partnership between AFDO and RAPS intends to continue that focus. We feel it is important to be key facilitator of the discussion.”

FDA has made education of the device manufacturing community a high priority to help ensure the quality of FDA-regulated medical products.

MedCon 2022 registration is now open. For more information and to view the virtual program details, visit www.healthcareproducts.org/MedCon. Information about the Collaborative and announcements for future events can be found at www.healthcareproducts.org.

Other FDA News of Interest

XT-Thrive® Drug Master File (DMF) Accepted by the FDA | Reports X-Therma

X-Therma notes this DMF covers the Chemistry, Manufacturing and Controls (CMC) for this key chemistry innovation, which enables non-toxic cryopreservation for life-saving regenerative medicines.

Simpson Interventions Receives FDA Breakthrough Device Designation for Acolyte™ Image Guided Crossing and Re-Entry Catheter System

Simpson Interventions is committed to collaborating closely with the FDA and other stakeholders to advance the development and regulatory review of the Acolyte Image Guided Crossing and Re-Entry Catheter System. The company looks forward to bringing this revolutionary technology to clinicians, and patients in need.

Transforming Tricuspid Valve Care: FDA Gives Green Light to Abbott’s TriClip™

"The U.S. approval of TriClip is a significant advancement for people suffering from tricuspid regurgitation, a heart condition that negatively impacts their quality of life and puts them at grave risk of serious health issues," said Paul Sorajja, M.D., the Roger L. and Lynn C. Headrick Family Chair of the Valve Science Center for the Minneapolis Heart Institute Foundation and director of the Center for Valve and Structural Heart Disease for the Minneapolis Heart Institute at Abbott Northwestern Hospital and co-principal investigator of the TRILUMINATE™ Pivotal trial. "With TriClip, physicians can offer patients a therapy option backed by excellent safety and effectiveness to help restore tricuspid native valve performance without subjecting them to high-risk open-heart surgery that may not be feasible for individuals with TR who are generally older and sicker."

spot_img

By using this website you agree to accept Medical Device News Magazine Privacy Policy